Neurodegenerative Disease Management has published it’s first plain language summary. The article, called ‘Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary’ is a summary of a study that examined side effects from cladribine tablets treatment in the first 12 weeks of two clinical studies called CLARITY and ORACLE-MS.
Read the full article here.
The original article on which this summary is based is called “Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two Phase 3 trials in multiple sclerosis”. The article was originally published in the journal Multiple Sclerosis Journal –
Experimental, Translational and Clinical and can be read here.